Syntrix Biosystems



Company News

 
 

Company News for immediate release.

 

Contact:

John A. Zebala, M.D., Ph.D.

President and CEO

253-833-8009

   
Home
Company
Drug Candidates
Research Platforms
Company News
Positions
Contact

 

Patents | Grant Awards | Press Releases

 

 

Grant Awards

September 10, 2003

  • R43DK62593.  Meta-molding arrays.  National Institute of Diabetes & Digestive & Kidney Diseases (Expanded Awards at NIDDK Program).  PI: John A. Zebala.

January 17, 2003

  • R43HL72614.  Bronchopulmonary dysplasia drug therapy.  National Heart, Lung & Blood Institute.  PI: Dean Maeda.

March 13, 2003

  • R44CA99126.  Artificial antibody mimetics.  National Cancer Institute (NCI IMAT Program).  PI:  John A. Zebala.

March 13, 2003

  • R44CA99333.  Instrumentation for the high-resolution analysis of cancer.  National Cancer Institute (NCI IMAT Program).  PI:  John A. Zebala.

October 14, 2002

  • WTC Project S03-B1.  Biochip-based combinatorial libraries for drug discovery.  PI:  William Atkins (University of Washington).

May 1, 2002

  • R44CA99612.  Snap-To-It PNA arrays.  National Cancer Institute.  PI:  John A. Zebala.

May 1, 2002

  • R44CA94419.  Light-Up PNA arrays.  National Cancer Institute (NCI IMAT Program).  PI:  John A. Zebala.

January 1, 2002

  • R43CA92800.  Novel GSTP inhibitors as potential oral myelostimulants.  National Cancer Institute (NCI FLAIR Program).  PI:  John A. Zebala.

 
   
 

Syntrix Biosystems, Inc.

215 Clay Street NW, Suite B-5, Auburn, WA  98001

TEL: 253-833-8009 • FAX: 253-833-8127

 

email: info@syntrixbio.com | contact us

© Copyright 2007 Syntrix Biosystems. All Rights Reserved.